The key promoters of startup village and one of the co-founder of Infosys Mr. Kris Gopalakrishnan has invested an undisclosed amount in Chennai-based speech recognition solutions company Uniphore Software Systems in a Series A round of funding. Existing investors IDG Ventures India, India Angel Network (IAN), Yournest Fund and Stata Venture Partners also participated in this round of funding.
The funding will fuel Uniphore’s global expansion and product and core technology development plans.
“Continuing on my theme of backing inclusive innovations, I am optimistic of the success of Uniphore. “Man-Machine communication is one of the more complex problems to solve. Uniphore’s vision lends possibility of finding a solution to this very difficult problem and the company has already made substantial progress” Kris Gopalakrishnan said in a statement.
“Gopalakrishnan’s experience in building mammoth and global businesses will help us move in the right direction. This investment is a powerful endorsement of Uniphore’s ability to provide value to our enterprise customers across industries through speech recognition technology. Additionally, these Series A funds help us attract the best of the talent the industry has to offer in this high-tech niche,” said Umesh Sachdev, co-founder and CEO, Uniphore Software Systems.
Launched in 2008, Uniphore’s solutions use speech as a medium for human-machine interaction and allow any software application to understand and respond to natural human speech. it had already raised $1 million in an angel round of funding and was incubated at IIT Madras, where it got a grant of $100,000 from National Research Development Corporation in 2008.
After Gopalakrishnan stepped down from the Infosys board last year, he has made select investments including Freshworld, a Bengaluru-based farm-to-fork fruit and vegetable delivery startup, and JetSynthesys, a digital and technology business firm. In January last year, he had established Pratiksha Trust along with wife Sudha Gopalakrishnan that is also investing in brain research.